PNG version of QUB Shield - Red


Registry Databases

Registry Databases

  • N. Ireland Barrett’s Oesophagus Register (NIBR)
  • Colorectal Polyps
  • Northern Ireland Endometrial Hyperplasia register
  • PSA Database

N. Ireland Barrett’s Oesophagus (NIBR)

The Northern Ireland Barrett’s oesophagus Register, led by Professor Liam Murray, is one of the largest population-based registers of Barrett’s worldwide, and now includes information on >13,000 incident diagnoses in Northern Ireland since 1993.  Barrett’s oesophagus is a pre-cursor condition for the cancer, oesophageal adenocarcinoma. Key publications from this work have demonstrated that:

Funding sources include: the UK Medical Research Council, Cancer Focus Northern Ireland (formerly the Ulster Cancer Foundation), NI HSC R&D Office, and Cancer Research UK.

Colorectal Polyps

The Colorectal Polyp Register includes information on all polyp diagnoses since 2000 in Northern Ireland (Joint PIs: Drs Marie Cantwell/Anna Gavin).  This resource has been used to investigate the risk of cancer in relation to type of polyps and findings show that elevated cancer risk remains in patients who have undergone polypectomy.  A joint molecular epidemiology study with Vanderbilt University, TN, USA, is ongoing using this resource to identify biomarkers for advanced recurrent adenomas.

Funding sources: Cancer Focus Northern Ireland.


Northern Ireland Endometrial Hyperplasia register

This new project aims to establish a population-based register of Endometrial Hyperplasia cases within the Northern Ireland Cancer Registry (PI: Dr Helen Coleman).  The register will improve our understanding of the prevalence of concurrent Endometrial Hyperplasia and cancer diagnoses, and allow estimations of cancer risk in Endometrial Hyperplasia cases who do not undergo hysterectomy.   The results will allow women to make informed treatment choices following an Endometrial Hyperplasia diagnosis. 


PSA Database

The N. Ireland Cancer Registry also hold a database on patients PSA test levels. This database is a population-based database of all PSA tests performed in NI biochemistry laboratories. The men on the database have their information linked to whether they have had a biopsy or were diagnosed with prostate cancer. Consequently, it is a valuable research resource for understanding the relationship between PSA levels in men’s blood and their risk of developing benign prostatic disease and/or malignant prostate cancer. PSA testing as a screening method for prostate cancer is highly controversial, and this population-based resource is capable of contributing to this international debate.